A Service For Professionals Saturday, August 19, 2017
Contact (202) 540-8337

Company News Today

A Service For Professionals Saturday, August 19, 2017 11435 Sources 399,041,530 Articles 3,328,029 Readers
Contact (202) 540-8337

World Market for Personalized Medicine Tests for Cancer 2017: Diagnostic Companies and Pharmaceutical Companies Analysis

/EIN News/ -- Dublin, March 08, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "The World Market for Personalized Medicine Tests for Cancer" report to their offering.

Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)

Key Topics Covered:

Chapter One Executive Summary

  • The Scourge of Cancer
  • Definitions of Companion Diagnostics and Cancer Diagnostics
  • Types of Tests Included
  • Marketing Personalized Medicine-Based Cancer Tests
  • Market
  • Point of View

Chapter Two Introduction

  • Cancer Treatments
  • Cancer Risk Assessment
  • Cancer Screening
  • Cancer Monitoring
  • Prognosis Assessment
  • Technologies Used
  • Immunoassays
  • Immunohistochemistry (IHC)
  • Flow Cytometry
  • In Situ Hybridization
  • Nucleic Acid Amplification Technologies
  • Analysis of Gene Expression Patterns (Gene Signatures)
  • Microarrays
  • Sequencing Technologies
  • Mass Spectrometry
  • Liquid Biopsies
  • Information Technology
  • Test Targets
  • HER2 Overexspression
  • EGFR
  • KRAS Mutations
  • BRAF Mutations
  • UGT1A1 Genetic Variants
  • 5-Flurouracil Therapy
  • PIK3CA Mutations
  • KIF6 Mutations
  • ALK Mutations

Chapter Three Market Analysis

  • Products on the Market
  • Market Analysis
  • Drivers
  • Diagnostic Companies and Pharmaceutical Companies
  • Growth by Geography

Chapter Four Company Profiles.

  • 20/20 GeneSystems, Inc.
  • Abbott Laboratories
  • ACT Genomics Co., Ltd.
  • Adaptive Biotechnologies Corporation
  • Admera Health (A GENEWIZ Company)
  • Agena Bioscience Inc.
  • Agendia NV
  • Amoy Diagnostics Co., Ltd.
  • ARKRAY, Inc.
  • Biocartis
  • bioMérieux SA
  • Cepheid (Danaher)
  • Genomic Health, Inc.
  • Genoptix (A Novartis Company)
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Qiagen N.V.
  • QuanDx Inc.
  • Quest Diagnostics
  • Qvella Corporation
  • RiboMed Biotechnologies, Inc.
  • Roche
  • Siemens Healthcare
  • Symbiodx
  • Theranostics Health Inc. (Acquired by Avant Diagnostics, Inc.)
  • Thermo Fisher Scientific, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/778jp3/the_world_market

                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             U.S. Fax: 646-607-1907
                             Fax (outside U.S.): +353-1-481-1716
                             Related Topics: Healthcare Services, Genomics, Diagnostics, Oncology Drugs 

Primary Logo

Powered by EIN News